FRANCISCO FIOL: Open Payments
NPI 1265073894 · LOGANVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,434 in 276 payments from 40 companies in 2025. Trend: 2023 $590 · 2024 $5,502 · 2025 $6,434
Food & beverage: $6,343Education: $91
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $577 |
| Axsome Therapeutics, Inc. | 13 | $540 |
| CATALYST PHARMACEUTICALS, INC. | 17 | $411 |
| Janssen Biotech, Inc. | 9 | $391 |
| PFIZER INC. | 27 | $375 |
| Lundbeck LLC | 15 | $360 |
| Neurelis, Inc. | 11 | $353 |
| UCB, Inc. | 15 | $298 |
| JAZZ PHARMACEUTICALS INC. | 6 | $251 |
| Novartis Pharmaceuticals Corporation | 10 | $218 |
Products named: NURTEC ODT, VYEPTI, FYCOMPA, Leqembi, VALTOCO, QULIPTA, KESIMPTA, ULTOMIRIS.
Industry payments across GA — which companies pay providers there.
